Top 50 Life Science Angel Investors in November 2024
A list of 50 angel investors that invest in Life science startups. We rank investors based on the number of investments they made in Life science companies. This investor list updates every month.Top 50 Life Science Angel Investors in November 2024
Investor | Life Science investments |
---|---|
Jonathan Milner | 10 |
Milad Alucozai | 5 |
Sahin Boydas | 5 |
bumpkins profile | 4 |
Nadav Rosenberg | 4 |
Esther Dyson | 3 |
Andrew Keys | 3 |
Erik Peterson | 3 |
Stefano Bernardi | 3 |
Bradley Horowitz | 3 |
Ian Hogarth | 3 |
Chris Gibson | 3 |
Darian Shirazi | 3 |
Balaji Srinivasan | 3 |
Kevin Moore | 3 |
Jude Gomila | 3 |
Mei Z. | 3 |
Andrew Nutter | 2 |
Jan Hruska | 2 |
Ahmed Abdelhamid | 2 |
Ed Parkinson | 2 |
Thor Bjorgolfsson | 2 |
Holger Hübner | 2 |
Robert Kopple | 2 |
Ryan Bethencourt | 2 |
Ankit Jain | 2 |
Carsten Maschmeyer | 2 |
Joshua Elkington | 2 |
Nitesh Banta | 2 |
Kathryn Haun | 2 |
Nicholas Edwards | 2 |
Sam Altman | 2 |
Annie Vereecken | 2 |
CJ Reim | 2 |
Mike Novogratz | 2 |
Patrick Collison | 2 |
Kevin Mahaffey | 2 |
James Hong | 2 |
Mark Evans | 2 |
David R. Walt | 2 |
Jay Zaveri | 2 |
Darrin Disley | 2 |
Jeff Dean | 2 |
Sauli Törmälä | 2 |
Lars Fjeldsoe-Nielsen | 2 |
Craig Mundie | 2 |
Elad Gil | 2 |
Peter Harris | 2 |
Pierre Drion | 2 |
David Helgason | 2 |
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Canada
Portfolio highlights
- Clock Bio — Clock Bio operates as a biotech company, that develops novel regenerative medicines.
- LIfT BioSciences — LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.LIfT BioSciences was founded in 2016 andheadquartered in London, England.
- Shift Bioscience — Explore cutting-edge simulation-guided cell rejuvenation techniques aimed at combating aging-related diseases.
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Sahin Boydas is an entrepreneur who has co-founded multiple startups in Silicon Valley, with extensive experience managing remote teams. As CEO of RemoteTeam.com, he addressed HR and operational challenges related to remote work. The company was acquired by Gusto in 2021, less than two years after its launch. Throughout the acquisition process,including investor pitching and team hiring, all interactions occurred virtually, with no in-person meetings.Boydas has been involved in several accelerator programs, including Stanford StartX, 500 Startups, and others. His earlier ventures include MovieLaLa, a movie marketing platform that reached 360 million users through partnerships before it was sold to Gfycat. He also co-founded MojiLaLa, a sticker marketplace, and Leo AR, a popular augmented reality app.
Show more
Investment focus
- Software, Financial Services, FinTech
- Seed, Series A, Series B
- United States, Mexico, Spain
Portfolio highlights
- Superunit — Superunit is a Software Development firm offering accounting and inventory solutions to their clients.
- Modus — Modus brings finance, HR, and hiring managers to detect, inspect, and correct their workforce plans - in one unified workflow. Hire and retain only the people you need, without the extra bloat.
- Cortex — Cortex makes it easy for engineering organizations to gain visibility into their services and deliver high quality software.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Pre-Seed
- United States, Canada, India
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Pharmaceutical
- Seed, Pre-Seed, Series A
- United Kingdom, Israel, Singapore
Portfolio highlights
- thymia — Making mental health as objectively measurable as physical health.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
- Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way
Esther Dyson - Founder @ Way to Wellville
Show more
Investment focus
- Health Care, Software, Medical
- Seed, Series A, Funding Round
- United States, Canada, Russian Federation
Portfolio highlights
- Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
- Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more
Investment focus
- Software, Finance, Blockchain
- Seed, Pre-Seed, Series A
- United States, India, Norway
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Erik Peterson is the Founder at DormTrader.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Seed, Equity Crowdfunding, Series A
- United States, Canada, Algeria
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more
Investment focus
- Software, Biotechnology, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- Italy, France, Norway
Portfolio highlights
- Freatic — Building the monetization layer for your alpha
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- United States, United Kingdom, Germany
Portfolio highlights
- Mill — Meet the cleanest, easiest way to prevent food waste at home. Mill recycles your peels, bones, stalks, and forgotten leftovers.
- Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
- Overture Life — We are making In Vitro Fertilization (IVF) more accessible than ever before while improving success rates. An embryology lab in a box.
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more
Investment focus
- Software, E-Commerce, Internet
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Germany
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Fabric — One home for everything. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files automatically gathered into one self-organizing home. Never forget anything again.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Seed
- United States, France, Switzerland
Portfolio highlights
- Amenities Health — Discover your dedicated Digital Front Door platform that enhances the patient experience and foster brand loyalty.
- Cradle — Design better proteins
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Darian Shirazi is the Managaing Partner of Gradient.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Series A, Series B
- United States, Germany, Canada
Portfolio highlights
- Valdera — Valdera is the sourcing and procurement platform that makes it easy to buy or sell chemicals, ingredients, and raw materials. We partner with segment leaders, ranging from the world's largest CPG manufacturers to household names in the beauty industry.
- Leya — By streamlining and simplifying legal workflows, we empower elite law firms and legal professionals to work more efficiently and effectively. Enabling them to focus on higher-value tasks and deliver exceptional results for their clients.
- rift — The sales platform built to help your focus.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more
Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Series A, Pre-Seed
- United States, India, Singapore
Portfolio highlights
- ZAR — Enjoy borderless banking with a USD Visa card powered by stablecoins. Available in 180+ countries. Sign up for your account today!
- The Arena — Arena. social is a cutting-edge SocialFi platform that is revolutionizing how content producers interact, network, and make money from their work.
- OpenGradient — OpenGradient is a leading decentralized AI platform for open-source model hosting, secure inference, agentic reasoning, and application deployment. By developing tooling and a feature-rich platform that makes developing AI workflows both secure and seamless, OpenGradient empowers developers with the ability to build in its ecosystem of intelligentand optimized AI-empowered applications. With native model hosting, permissionless composability, and secure inference execution, OpenGradient also aims to accelerate open-source AI by democratizing model ownership, improving verifiability guarantees, and promoting censorship-resistant model access.Our heterogeneous AI compute architecture (HACA) and our proprietary library NeuroML scale secure AI workflows with features like inference, agentic reasoning, statistical analysis, and more. OpenGradient also accelerates open-source innovation with a web portal and SDK for Web2 developers to leverage our AI stack without navigating blockchain complexities, while enjoying the security and composability benefits of decentralized infrastructure.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Pre-Seed, Angel
- United States, India, Canada
Portfolio highlights
- Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Augmend — Create documentation and an AI assistant from any video.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Pre-Seed, Angel
- United States, United Kingdom, Canada
Portfolio highlights
- Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
- HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Singapore
Portfolio highlights
- Coframe — Transform your website with AI-driven optimization and personalization that boosts engagement and conversions. Coframe automates growth 24/7.
- Exa — Exa is an AI research center that is reinventing the quest for AI.
- The San Francisco Compute Company — The San Francisco Compute Company manufactures supercomputers.
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Pre-Seed, Funding Round
- France, United Kingdom, United States
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Jan Hruska
Show more
Investment focus
- Medical, Health Care, Life Science
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Ahmed Abdelhamid is Partner at Endure Capital. He attended Vlerick Business School.
Show more
Investment focus
- Aerospace, Biopharma, Life Science
- Seed, Convertible Note
- Egypt, United States
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
- Wright Electric, Inc. — Wright Electric, Inc. is building technologies for large commercial airplanes. The company is currently developing their flagship Airplane, the Wright 1, which will be a 186-seat single aisle airliner with an 800 mile range. The company hopes to achieve entry to service for the Wright 1 by 2030 and is working with commercial airlines includingeasyJet and VivaAerobus. In addition to the newly announced U.S. DOE’s ARPA-E funding, the company is funded by Y Combinator, the Clean Energy Trust and venture funds.
Ed Parkinson
Show more
Investment focus
- Software, Health Care, Life Science
- Seed
- United Kingdom
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more
Investment focus
- Big Data, TV, TV Production
- Seed, Series A, Series C
- United Kingdom, Germany
Portfolio highlights
- Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- ATAI Life Sciences — ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
Holger Hübner
Show more
Investment focus
- B2B, SaaS, Audio
- Seed, Pre-Seed
- Germany
Portfolio highlights
- musicube — Good music deserves to be found. That is why musicube develops revolutionary music search technology. Music streaming services and other companies can forward any user request to musicube and get back high quality data in real time (e.g. to return playlists etc.).
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Robert Kopple
Show more
Investment focus
- FinTech, Finance, Life Science
- Funding Round, Convertible Note
- United States, United Kingdom
Portfolio highlights
- Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
- ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more
Investment focus
- Biotechnology, Food Processing, Food and Beverage
- Pre-Seed, Seed, Angel
- United States, Chile, India
Portfolio highlights
- WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
- Sobo Foods — Sobo Foods is a plant based comfort food provider.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more
Investment focus
- Health Care, Medical, Hospital
- Seed, Pre-Seed
- United States
Portfolio highlights
- Advex AI — Advex AI assists the world's largest manufacturers in cutting costs and increasing productivity by producing highly dependable computer vision models in hours.
- RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
- Empower Sleep — Empower Sleep provides personalized sleep care online
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more
Investment focus
- Software, Information Technology, Machine Learning
- Seed, Angel, Series A
- Germany, Austria, Switzerland
Portfolio highlights
- frats — frats' goal is to become a solution-oriented company in the party, event, and festival market for sustainable products.
- Futurised — Futurized makes processes simple and intelligent by providing businesses with software robots that automate all unpleasant and complex operations using AI.
- Bildungs urlauber — The goal of Bildungsurlauber.de is to make complicated topics simple. First and foremost, we assist you in locating the appropriate seminar for you by using simple filter options - regardless of whatever federal state you work in.
Joshua Elkington
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Seed
- United States
Portfolio highlights
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
- Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Nitesh Banta is the Co-Founder & CEO at B12.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- United States, Canada, India
Portfolio highlights
- Protege — Protege is the platform for AI Training Data. Protege works with data holders and model builders to empower them to share training data for AI model development.
- Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
- Draftboard — Refer your friends, community and following with our hiring platform, and get paid when they get hired! Start referring (or hiring!) now!
Katie Haun is a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School. Previously, she spent a decade as a federalprosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.
Show more
Investment focus
- Blockchain, Financial Services, FinTech
- Funding Round, Seed, Series A
- United States, United Kingdom
Portfolio highlights
- dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
- Aptos — Building products, applications, and tooling on the Aptos blockchain. Bringing the benefits of decentralization to the masses.
- Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more
Investment focus
- Medical, Health Care, Life Science
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator from 2016 through 2019.
Sam Altman attended Stanford University.
Show more
Investment focus
- Software, Internet, Artificial Intelligence
- Seed, Series A, Series B
- United States, Canada, Ghana
Portfolio highlights
- GALY — Saving Our Planet by Transitioning the World to Cellular Agriculture
- Beacon AI — Beacon AI is building the future of flight safety for commercial and private fleets.
- ValueBase — This page discusses the history of ValueBase, what brought us together and why we decided that accurate appraisal was important. It also explains why we focus on mass appraisal and statistical techniques like regression.
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more
Investment focus
- Robotics, E-Commerce, Internet
- Series A, Seed, Series B
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Michael E. Novogratz is the CEO of Galaxy Investment Partners. He was formerly a principal and a member of the board of directors of Fortress Investment Group LLC and Chief Investment Officer of the Fortress Macro Fund. Mr. Novogratz joined Fortress in 2002 after spending 11 years at Goldman Sachs, where he was elected partner in 1998. Mr.Novogratz founded and serves as the Chairman of the Board for Beat the Streets, a non-profit organization which builds wrestling programs in New York City public schools and is also the Honorary Chairman of USA Wrestling Foundation. Mr. Novogratz is Chairman of The Friends of the Hudson River Park. He also serves on the board of the Acumen Fund, NYU Langone Medical Center, Princeton Varsity Club and The Jazz Foundation of America. Mr. Novogratz received an AB from Princeton University in Economics, and served as a helicopter pilot in the US Army.
Show more
Investment focus
- Blockchain, Cryptocurrency, FinTech
- Seed, Funding Round, Series B
- United States, India, Germany
Portfolio highlights
- Portal — The only custody-less interoperability protocol for Bitcoin. Swap native BTC, Ordinals, Runes with L2s and L1s
- Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
- Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Patrick Collison is the Co-Founder, CEO and Content Strategist of Stripe. He previously worked at Auctomatic as a Co-Founder. Patrick Collison attended Massachusetts Institute of Technology.
Show more
Investment focus
- Software, Information Technology, Financial Services
- Seed, Series A, Series C
- United States, United Kingdom, India
Portfolio highlights
- Cortex — Cortex makes it easy for engineering organizations to gain visibility into their services and deliver high quality software.
- Pacific Fusion — Pacific Fusion was founded in 2023 with the mission to power the world with abundant, affordable, clean energy.
- The Bot Company — The Bot Company a household robot startup.
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more
Investment focus
- Software, SaaS, Enterprise Software
- Seed, Series A, Pre-Seed
- United States, Canada, Israel
Portfolio highlights
- bem — Engineering teams use bem to transform any data point into whatever shape they need.
- Resquared — Resquared has everything you need and more to reach local businesses. Contact data on every local business, optimized email and social outreach tools, and step-by-step built-in playbooks.
- Token Security — Token is the new approach designed for the identity boom era. Introducing Machine-First Identity Security.
James Hong
Show more
Investment focus
- E-Commerce, Mobile, Internet
- Seed, Series A, Angel
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Series A, Seed, Series C
- United Kingdom, United States, The Netherlands
Portfolio highlights
- ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
- Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more
Investment focus
- Biotechnology, Genetics, Life Science
- Seed, Series A, Series B
- United States
Portfolio highlights
- Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Jay Zaveri has been serving Social Capital as a partner since November 2015. He also founded CloudOn and Future Thought Productions.
Show more
Investment focus
- Health Care, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- United States, Japan, Canada
Portfolio highlights
- Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
- BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
- Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more
Investment focus
- Biotechnology, Health Care, Big Data
- Seed, Series A, Funding Round
- United Kingdom
Portfolio highlights
- bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a codesigner and coimplementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open-source system for machine learning.Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM-Infosys Foundation Award in the Computing Sciences.
Show more
Investment focus
- Artificial Intelligence, Biotechnology, Health Care
- Seed, Series A, Pre-Seed
- United States, Japan, Australia
Portfolio highlights
- Letta — Letta specializes in memory management technology, enabling AI models to remember users and conversations. Its featured products include Hosted Cloud and Lett_ API. Hosted Cloud creates, deploys, and manages agents at scale with Letta Cloud. Also, its Lett_ API adds memory to LLM services to give them reasoning capabilities and transparentlong-term memory powered by MemGPT.
- TollBit — The platform for AI content licensing at scale. TollBit helps you monitor AI traffic, manage licensing deals & monetize your content in the AI era.
- Resolve.ai — Resolve AI is a firm dedicated on automating software processes. The company creates AI solutions that can automatically troubleshoot and resolve manufacturing challenges.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more
Investment focus
- Life Science, Biotechnology
- Seed
- Finland
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Lars Fjeldsoe-Nielsen is a Co-Founder & serves as a Partner at 2xN. Lars Fjeldsoe-Nielsen was General Partner at Balderton Capital in London from 2015-2021 through four funds. He joined after spending a decade in Silicon Valley where he was with Uber and Dropbox.Since 2012 his venture track record includes two IPOs (Uber, Dropbox) and 11acquisitions.Lars joined Balderton from Uber which he joined when the company was operating in less than 20 cities. His role as Vice-President resulted in strategic alliances. Lars joined Uber from Dropbox as one of the company’s first 25 employees. As Head of Mobile, his growth deals with Samsung and other mobile OEMs helped Dropbox reach its first 100 million users. Prior to that Lars held positions at Voicesignal (acq. Nuance), Skyhook Wireless (acq. TruePosition), Ness Technologies (acq. Opentable), 3Jam (acq. Skype) and T9 Tegic (acq. AOL). More than a billion people have used the software and services distributed as a result of mobile growth partnerships led by Lars.His venture investments include Voi (Raine), Labster (A16Z), Hiya (Ericsson), Cambridge Quantum Computing (HON), Hopin (A16Z), Opensea (A16Z), Yassir (YC), Beacon (Eric Schmidt), The org (Sequoia), Octant (A16Z), Zycada (Khosla), Monarch Money (Accel) and Kukua (Tencent), Dubsmash (acq. Reddit), Tempow (acq. Google), Rahko (acq. Odyssey Therapeutics), Pocket (acq. Mozilla), Blue Bottle (acq. Nestle), Marble (acq. Caterpillar).Lars, who is Danish-Portuguese, grew up across Africa and served with the Royal Danish Guards. He holds a MBA from London Business School, where he also serves on the Board of Trustees, an MSc from Oxford University Keble College and a BSc from King’s College, London. He lives in London with his wife and three children.
Show more
Investment focus
- Software, Information Technology, Mobile Apps
- Seed, Series A, Funding Round
- United States, Denmark, United Kingdom
Portfolio highlights
- HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
- LiveFlow — The easiest way to bring financial data into your spreadsheet. Automate your finances, consolidate your accounts and collaborate in real-time. Try LiveFlow for free today!
- Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more
Investment focus
- Life Science, Chemical, Genetics
- Seed, Series B, Series C
- United States
Portfolio highlights
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Series B
- United States, United Kingdom, Israel
Portfolio highlights
- Magic — Teaching AI to act in its natural environment, the computer.
- Harvey — Harvey builds custom LLMs for elite law firms to tackle the most complex legal challenges across every practice area, jurisdiction and legal system in the world.
- Applied Intuition — Applied Intuition enables engineering and product development teams to safely develop, test, and deploy autonomous vehicles at scale.
Peter Harris
Show more
Investment focus
- Life Science, Biotechnology, Health Diagnostics
- Seed
- United States
Portfolio highlights
- CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more
Investment focus
- Software, Gaming, Information Technology
- Seed, Funding Round, Pre-Seed
- United States, Denmark, Finland
Portfolio highlights
- Isometric — Isometric is a carbon removal standard and registry.
- Slope — We handle the lending, underwriting, debt collection and fully pay out to you immediately once the product or service ships.
- Rocky Road — At Rocky Road, we are redefining social gaming with our social gaming network. We are hiring!
Investors by industry
Health Care
Google
Gaming
Climate
Energy
Community
Marketplace
Hardware
Biotech
Consumer
Proptech
Artificial intelligence
FinTech
Impact
EdTech
Sustainability
Venture Capital
Fashion
Big Data
Finance
Web3
B2B
Beauty
Retail
Education
Clean Energy
Oil and Gas
Food and Beverage
Real Estate
Video Games
Payments
Infrastructure
Photography
Financial Services
Organic Food
Publishing
Social Media
Social Network
Wellness
Enterprise Software
Medical
Android
Digital Media
Music
Legal
Franchise
Local
Internet
Construction
Sports
eSports
Manufacturing
Email
Mobile
Art
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Platforms
Cannabis
Mobile Advertising
Medical Device
Automotive
Wine And Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Theatre
Film
Life Science
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
India
Canada
South Korea
Australia
Ireland
New Zealand
United States
Africa
Vietnam
Saudi Arabia
Japan
South Africa
Europe
Oceania
LATAM
Indonesia
Middle East
Asia
Sri Lanka
China
Singapore
Brazil
Armenia
Qatar
Spain
Chile
Belgium
France
Belarus
Egypt
Ghana
Croatia
Ethiopia
Costa Rica
Gibraltar
Greece
Finland
Belize
Denmark
Hong Kong
Barbados
Bahrain
Hungary
Georgia
Bermuda
Czech Republic
Ecuador
Bulgaria
Algeria
Estonia
Faroe Islands
Kenya
Lithuania
Liechtenstein
Panama
Myanmar
Lebanon
Cayman Islands
Mexico
Philippines
Mali
Norway
Malta
Israel
Italy
Kazakhstan
Cambodia
Peru
Kuwait
Malaysia
Nicaragua
Slovenia
Thailand
Uzbekistan
Serbia
Zimbabwe
Sierra Leone
Zambia
Venezuela
Liberia
Taiwan
Togo
Portugal
Turkey
Seychelles
San Marino
Uganda
Mauritius
Rwanda
Uruguay
Ukraine
Sweden
Senegal
Tanzania
Tunisia
Russian Federation
El Salvador
Poland
Puerto Rico
Tajikistan
Morocco
Dominican Republic
Jersey
Iraq
Bahamas
United Arab Emirates
Azerbaijan
Nigeria
Honduras
Iceland
Bolivia
Isle of Man
Namibia
Luxembourg
Pakistan
Albania
Oman
Argentina
Jordan
Bangladesh
Grenada
Romania
Cyprus
Latvia
Colombia
Cameroon
Austria
Switzerland
Guatemala
Marshall Islands
Angel Investors in life science by country